Speaker Profile

Vice President of Corporate Development, Ciitizen

Biography
Farid Vij is Vice President of Corporate Development at Ciitizen where he drives the company’s go-to-market strategy and engagements with partners including patient advocacy organizations, providers and biotech/biopharma. Farid’s focus is on creating a scalable model that allows advocacy partners and patients to garner value through sharing their health data yet retaining control of it at all times. He believes there is a sustainable way to drive patient-driven research by ensuring patients always gain benefit through their participation. Prior to Ciitizen, Farid was Global Head of Sales & Business Development at ZL Technologies where he led the development and launch of ZL’s Big Data cloud business to support legal compliance with GDPR and built a global sales and marketing organization across four regions. Farid received a B.S. in Economics from the Wharton School at the University of Pennsylvania.


 Session Abstract – PMWC 2020 Silicon Valley


Precision medicine has incredible promise for patients. Enormous amounts of money and time are invested in developing technologies and targeted therapies. Genomics, proteomics, phosphorylation assays, RNA expression, organoid growth, and testing, and even delicate mass measurement of liquid cancer cells are explored. This innovation must be focused to maximize the benefit to the most important participants in our healthcare system, the patient. This track is about putting patient needs first, and understanding and accessing the latest (cancer) treatment options.

  • Overview for Patients: The Latest Cancer Treatments
    In this session, you will hear from industry leaders about the latest strategies for diagnosing and treating cancer, the latest targeted- and immunotherapies, and the latest techniques for catching cancer early when it is most vulnerable. These breakthroughs could save your life or that of a loved one.
    - Jennifer Grandis, UCSF
    - Cliff Hudis, ASCO
    - Craig Lipset, Clinical Innovation Partners LLC
    - Richard Wender, American Cancer Society
  • Overview for Patients: Latest Tech In Oncology
    Oncologists are increasingly using technology to precisely diagnose the biological mechanisms driving a patient’s tumor, to predict which therapies are likely to be most effective in block-ing them, and to monitor the patient’s response in real time. Learn how these technologies are transforming the practice of oncology into a science.
    - Vik Bajaj, Foresite Capital
    - Matt De Silva, Notable Labs
    - Gary Palmer, Tempus, Inc.
    - Daniel Simon, Guardant Health
    - Margaret McCusker, Flatiron Health
  • How Patients Get What They Need
    The latest treatment options are not an option if you can’t get or afford them. Learn about the novel strategies top docs use to access breakthrough tests and therapies for their patients through clinical trials, expanded access and contingent reimbursement.
    - Eric Marton, Wavemaker 360
    - June Wasser, Consultant
    - Martin Naley, OctX
    - Conrad Vial, Sutter Health
    - Maurie Markman, CTCA Health
  • Summary for Patients: So What- Putting It Together
    For nearly a decade, non-profit Cancer Commons has helped thousands of patients and their physicians beat the odds with information about the latest tests and treatments. New software and industry partnerships are taking this to the next level, where treatment decisions are in-formed by the latest tech, a treatment’s accessibility, and the collective experience of all patients and physicians.
    - Marty Tenenbaum, Cancer Commons
    - Carla Grandori, SEngine Precision Medicine
    - Mika Newton, xCures
    - Conan Kinsey, Huntsman Cancer Center
    - Jim Snyder, Henry Ford Health System
    - Erika Monteverdi, Cancer Commons
    - Harvey Cohen, Stanford University

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by AUG. 1ST

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required